At Adimab, we leverage our proprietary yeast-based antibody discovery and optimization platform to provide the biopharmaceutical industry with human therapeutic antibodies of the highest quality. We partner with top-tier pharmaceutical companies, progressive academic institutions, and innovative biotechnology companies who share our passion for bringing best-in-class molecules to patients.
Adimab has established antibody discovery collaborations with many leading pharmaceutical companies, such as Merck, Novo Nordisk, Biogen, GSK, Roche, Novartis, Eli Lilly, Genentech, Celgene, Gilead, Kyowa Hakko Kirin, Takeda, and Sanofi. The Adimab antibody discovery and optimization platform has been internalized by several pharma partners; Adi-inside partners include Merck, Novo Nordisk, Biogen, and GSK. In addition, Adimab has partnered with several smaller publicly traded companies, such as Acceleron, Merrimack Pharmaceuticals, Kite, and Five Prime, as well as leading venture-backed companies including Jounce, Mersana, Alector, Arsanis, Surface Oncology, Potenza, Tizona, Tusk, and several academic institutions such as Memorial Sloan Kettering and MD Anderson.
We are seeking an experienced scientist to join our Computational Biology group. The successful candidate will have prior experience in method and software development for structural modeling of proteins and protein:protein interactions. Candidates with experience in developing conformational sampling schemes or energy functions for protein design are especially encouraged to apply. Particular application areas for this role include antibody library design and developability assessment of therapeutic antibodies. The position will be located in Palo Alto, CA and will closely interface with a team of scientists from Protein Analytics and Antibody Discovery located in Lebanon, NH.
Needed upon hire
Our integrated antibody discovery and optimization platform provides unprecedented speed from antigen to purified, full-length human IgGs. We offer fundamental advantages by delivering diverse panels of therapeutically relevant antibodies that meet the most aggressive standards for affinity, epitope coverage, species cross-reactivity, and developability. We enable our partners to rapidly expand their biologics pipelines through a broad spectrum of technology access arrangements.
As a profitable privately-held biotech company, we take a long-term view on value creation and make substantial investments in technology development, research, and our people. We proudly promote meritocracy and reward employees who are productive, use their resources wisely, and make meaningful contributions to the team. We offer individually tailored compensation packages comprised of competitive salary, equity, a 2:1 401(k) match, and comprehensive health care benefits.
Located in New Hampshire’s beautiful Upper Connecticut River Valley, Adimab is minutes from Dartmouth College, the Geisel School of Medicine, the Thayer School of Engineering, the Tuck School of Business, and the Dartmouth Hitchcock Medical Center. We are fortunate to be situated in an area that is renowned for its premier skiing, hiking, kayaking, and biking.